Government nearly exhausts monoclonal COVID treatment funding with new purchase
GlaxoSmithKline (WASHINGTON) --- Eli Lilly has announced the U.S. government is buying an additional 150,000 courses of the only monoclonal antibody therapy left that still holds u…